David Boulware

Strategy Trial of Personalized Immunomodulatory Therapy for HIV-Related Cryptococcal Meningitis

National Institute of Allergy and Infectious Diseases · U01

Contact PI · $646.3K · University of Minnesota

Infectious Disease Training in Clinical Investigation

National Institute of Allergy and Infectious Diseases · T32

Contact PI · $3M · University of Minnesota

Midcareer Mentoring for Clinical Research in HIV/AIDS-Related Cryptococcal and TB Meningitis

National Institute of Allergy and Infectious Diseases · K24

Contact PI · $647.6K · University of Minnesota

Improving Diagnostics and Neurocognitive Outcomes in HIV/AIDS-Related Meningitis

National Institute of Neurological Disorders and Stroke · R01

Contact PI · $8.3M · University of Minnesota

B-PaLMZ for TB Meningitis

Principal investigator · Recruiting · Phase 2

David Boulware

Platform Trial For Cryptococcal Meningitis (PLATFORM-CM)

Principal investigator · Recruiting · Phase 2, Phase 3

David Boulware

Optimizing the Dose of Flucytosine for the Treatment of Cryptococcal Meningitis

Principal investigator · Completed · Phase 2

University of Minnesota

Encochleated Oral Amphotericin for Cryptococcal Meningitis Trial 3

Principal investigator · Unknown · Phase 3

Matinas BioPharma Nanotechnologies, Inc.